Provider
QP83-23 Commercial Pharmacy Benefit Exclusion for Budesonide-Formoterol Aerosol Inhaler and Tiotropium Bromide Inhalation Capsule
Program effective Date: Oct 11, 2023
Search Results
Displaying 1371 - 1380 of 3697 results
Provider
QP84-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2023
Program effective Date: Oct 11, 2023
Provider
QP85-23 MHCP Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Elrexfio™, Izervay™, Talvey™, and Veopoz™
Program effective Date: Oct 11, 2023
Provider
QP86-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2023
Program effective Date: Oct 11, 2023
Provider
QP87-23 Availity Essentials Updated Claim Entry Forms
Program effective Date: Oct 11, 2023
Provider
Rho Kinase Inhibitor - Commercial
Quantity Limit
Program effective Date: Nov 01, 2024
Provider
Joenja (leniolisib) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Aug 01, 2025
Provider
Rezurock (belumosudil) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2025
Provider
QP55R1-23 Change in Processing for Replacement Claims
Program effective Date: Oct 11, 2023
Provider
QP80-23 Blue Cross Response to Medical Oncology Drug Shortage of Cisplatin and Carboplatin
Program effective Date: Oct 11, 2023